Chapter

Antioestrogens

John F. Forbes

in Endocrine Therapies in Breast Cancer

Published on behalf of Oxford University Press

ISBN: 9780199218141
Published online May 2011 | e-ISBN: 9780199606993 | DOI: http://dx.doi.org/10.1093/med/9780199218141.003.0003

Series: Oxford Oncology Library

Antioestrogens

Show Summary Details

Preview

• Oestrogen acts via nuclear oestrogen receptors and (ER) formation of the ER oestrogen complex triggers transcription. • Antioestrogen treatments include selective oestrogen receptor modulators (SERMs), and strategies to reduce oestrogen levels by suppression of ovary function in premenopausal women and by blocking the aromatase enzyme in postmenopausal women. • Tamoxifen is the most important SERM. It is effective, generally well tolerated, and inexpensive. It is active against both early and advanced breast cancer and is an effective preventative agent for women at increased risk. • Other SERMs include raloxifene which is an effective prevention agent. • Antioestrogen therapies will remain important for breast cancer treatment and prevention. Drugs with a better side effect profile are needed.

Chapter.  2311 words.  Illustrated.

Subjects: Clinical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.